Literature DB >> 3684392

Coronary artery involvement in Kawasaki syndrome in Manhattan, New York: risk factors and role of aspirin.

F Ichida1, N S Fatica, M A Engle, J E O'Loughlin, A A Klein, M S Snyder, K H Ehlers, A R Levin.   

Abstract

Since January 1980, 110 children having 113 attacks of Kawasaki syndrome were studied. Age at onset was 7 weeks to 12 years (mean 3 6/12 years, median 2 9/12 years); 77% were younger than 5 years of age; the male to female ratio was 1.8; racial distribution was 52% white, 19% black, 14% Hispanic, and 16% Asian. Protocol of management consisted of high-dose aspirin (100 mg/kg/d) until afebrile, and then 81 mg every day until free of coronary aneurysm. Two-dimensional echocardiograms were done weekly during the acute stage, at 2 and 6 months after onset, and yearly if a coronary abnormality was detected. At 1 month, 51 coronary arterial abnormalities were present in 25 patients. Risk factors for a coronary abnormality were duration of fever greater than or equal to 2 weeks, level of platelet count, marked elevation of ESR, and age younger than 5 years. No statistically significant difference in incidence of aneurysms was detected between patients on high-dose aspirin and those on medium-or low-dose aspirin.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3684392

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  15 in total

Review 1.  Kawasaki syndrome: lessons for Britain.

Authors:  J G Bissenden; S Hall
Journal:  BMJ       Date:  1990-04-21

2.  Sudden death in incomplete Kawasaki disease.

Authors:  M D Loubser; M C Hoh; N Sreeram
Journal:  Arch Dis Child       Date:  1989-04       Impact factor: 3.791

Review 3.  Pharmacological therapy for patients with Kawasaki disease.

Authors:  R V Williams; L L Minich; L Y Tani
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

4.  Kawasaki Disease and Labyrinthitis: An Underdiagnosed Complication.

Authors:  Kyu Yeun Kim; Ki Hwan Kim; Yoon Ah Park; Young Joon Seo
Journal:  J Audiol Otol       Date:  2017-03-30

5.  Management of Kawasaki disease in the British Isles.

Authors:  R Dhillon; L Newton; P T Rudd; S M Hall
Journal:  Arch Dis Child       Date:  1993-12       Impact factor: 3.791

6.  Evaluation of the efficacy of treatment of Kawasaki disease before day 5 of illness.

Authors:  N C Fong; Y W Hui; C K Li; M C Chiu
Journal:  Pediatr Cardiol       Date:  2003-10-13       Impact factor: 1.655

Review 7.  Salicylate for the treatment of Kawasaki disease in children.

Authors:  J H Baumer; S J L Love; A Gupta; L C Haines; I Maconochie; J S Dua
Journal:  Cochrane Database Syst Rev       Date:  2006-10-18

Review 8.  Epidemiology and management of Kawasaki disease.

Authors:  Nadia J C Luca; Rae S M Yeung
Journal:  Drugs       Date:  2012-05-28       Impact factor: 11.431

9.  Diagnosis of incomplete Kawasaki disease.

Authors:  Jeong Jin Yu
Journal:  Korean J Pediatr       Date:  2012-03-16

Review 10.  Can Coronary Artery Involvement in Kawasaki Disease be Predicted?

Authors:  Sunil J Ghelani; Neha S Kwatra; Christopher F Spurney
Journal:  Diagnostics (Basel)       Date:  2013-03-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.